Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
12 February 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
Prof Angelique van Niekerk and CP Naude
Charl-Pierre Naudé with Prof Angelique van Niekerk after launch and discussion of his book.

Die Ongelooflike Onskuld van Dirkie Verwey is the debut novel by Charl-Pierre Naudé, research fellow in the Department of Afrikaans and Dutch, German and French at the University of the Free State (UFS).

Naudé has published four volumes of poetry and is a poet by profession. Die Ongelooflike Onskuld van Dirkie Verwey is his first leap from poetry to prose. He is also a former winner of the Ingrid Jonker Prize for poetry.

The book, published by Tafelberg, was launched on the UFS Bloemfontein Campus on Thursday 30 January 2019 where Naudé was in conversation with Dr Francois Smit, also from the Department of Afrikaans and Dutch, German and French, during which the two of them attempted to analyse the world of the main characters; however, Naudé did not want to give away too much. ”I think people should read the book,” he said.

Spiritual and physical worlds

 

“The novel is a first-person narrative told by one of the characters. I wanted to play a certain bluff to determine exactly who the author of this book was,” said Naudé. The book is not totally explicable. “I wanted the reader to feel that it is not absolutely true.”

''The book seeks to combine the spiritual and physical worlds,” said Naudé. Die Ongelooflike Onskuld van Dirkie Verwey is essentially a love story in which the two worlds merge, but nonetheless never mix.

 

Creative writing course revived

 

“The book is Charl-Pierre’s creative output which forms part of his creative writing course,” said Head of Department, Prof Angelique van Niekerk. This is the first book published after the revival of the creative writing course at the UFS in 2015 – and what a book to kick off with!

“It is of great importance for our department to have been part of this book,” Dr Smith said.

Read here the article published in Huisgenoot.

News Archive

Collaboration between UFS and Mayo Clinic to revolutionise cancer treatment
2014-06-27



Attending the lecture were, from the left: Dr Chantel Swart, Prof Lodewyk Kock, Prof Debabrata Mukhopadhyay, Prof James du Preez; back: Prof Pieter van Wyk. Dr Swart, Profs Kock and Du Preez are from the Department of Microbial, Biochemical and Food Biotechnology. Prof Mukhopadhyay is from the Mayo Clinic (US) and Prof Van Wyk is from the Centre for Microscopy at the UFS.
Photo: Supplied
The UFS made a discovery that may have enormous implications for the treatment of diseases in humans.

Since the discovery, the UFS joined forces with the Mayo Clinic in Rochester, US, in the fight against cancer.

In this collective effort, UFS researchers would be able to assist the Mayo team to:
• see how treatment in cancer patients is progressing,
• target treatments more effectively,
• reduce dosages in order to make treatment gentler on the patient,
• track the effectiveness of the chemotherapy drugs used, and
• gain an accurate view of how the cancer is being eliminated.

Prof Lodewyk Kock, Outstanding Professor at the Department of Microbial, Biochemical and Food Biotechnology, and his team incidentally created a technique to use argon gas particles for the first time on biological material to slice open cells to look inside.

The team that supported Prof Kock includes Dr Chantel Swart, Khumisho Dithebe (PhD student), Prof Hendrik Swart (Department of Physics) and Prof Pieter van Wyk (Centre for Microscopy).

Prof Debabrata Mukhopadhyay from the Mayo Clinic in Rochester, US, got to hear about this breakthrough at the UFS and a collaboration between the two institutions was established.

During a visit to the Bloemfontein Campus, Prof Mukhopadhyay explained novel techniques that make use of gold nanoparticles. These particles attach to chemotherapeutic drugs to selectively target cancer cells – dramatically decreasing the side effects to normal human cells.

For these new drugs (coupled to gold nanoparticles) to be accepted into clinical practice, visual and chemical proof is needed, though. This is where the technique developed by the UFS will play a vital role.

With the technique to look inside cells, the composition, location and metabolism of these drugs can be determined. This will aid in a proof of concept for the application of the nano-drugs. Furthermore, it will enable approval for use of these drugs in clinical trials and eventually could revolutionise cancer treatment as a whole.

For video lectures on the technique used, as well as its findings, follow these links:

1. http://vimeo.com/63643628 (Comic version for school kids)

2. http://vimeo.com/61521401 (Detailed version for fellow scientists)

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept